Pharmacy Times®
Specialty Pharmacy Times
  • Biosimilars: The Perfect Fit for Specialty!
  • Price vs Patient Access: Specialty’s Unsettling Conundrum
  • What to Remember About Refill Reminders
  • USP <800>: New Regulations to Protect Health Care Workers from Hazardous Drugs
  • The FDA’s Outsourcing Facility Designation: What It Means and Why It Matters
  • Specialty Pharmacists Play a Vital Part in the Treatment of Hepatitis C
Delaying Hepatitis C Treatment Increases Death Risk
Davy James, Managing Editor
Delays can negatively affect treatment efficacy and the risk of morbidity and mortality among patients.
Prime Time for HIV Prevention Counseling
Rachel Lutz
Expanded hours may be needed to overcome treatment obstacles.
Breakthrough Hepatitis C Drug Highlights Specialty Pharmacy Week in Review
Davy James, Managing Editor
A look back at the top stories of the week on Specialty Pharmacy Times from April 27 to May 1.
Farydak by Novartis Pharmaceuticals
Michael R. Page, PharmD, RPh
The FDA approved Farydak (panobinostat) as part of a 3-drug regimen for management of multiple myeloma in treatment-experienced patients.
Triumeq by ViiV Healthcare
Michael R. Page, PharmD, RPh
The FDA approved Triumeq (abacavir, dolutegravir, and lamivudine) tablets for the treatment of HIV-1 infection in patients without the HLA-B*5701 allele.
Featured Video
Specialty Pharmacy and the Evolution of Cancer Care
Kjel Jonhson, PharmD, Vice President of Global Oncology for IMS Health, discusses the changing role of specialty pharmacy in cancer treatment.
Industry Guide
We've created this Industry Guide with close to 300 companies and organizations as a one-stop guide for industry stakeholders in the specialty pharmacy space.
Current Issue
Volume: 6
Number: 2
Conference Calendar
       May 2015       
Featured Company Profile
HIV Pharmacists: Critical Partners on the HIV Care Team
The American Academy of HIV Medicine has certified thousands of providers with specialist or expert designations.
Pharmacy Times
Intellisphere, LLC
666 Plainsboro Road
Building 300
Plainsboro, NJ 08536
P: 609-716-7777
F: 609-716-4747

Copyright Specialty Pharmacy Times 2006-2015
Intellisphere, LLC. All Rights Reserved.